HSPD1 and neoplasm: This process establishes a potentially pathogenic feedback loop: the release of Hsp60-bearing exosomes from dysplastic or pre-malignant epithelial cells may reinforce chronic inflammation and immune activation, or paradoxically, drive immune tolerance and tumor immune evasion [10].